NAMITHA KACHE: Open Payments
NPI 1770045171 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,874 in 150 payments from 18 companies in 2025. Trend: 2023 $1,149 · 2024 $1,511 · 2025 $3,874
Food & beverage: $3,770Education: $104
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 23 | $570 |
| GENZYME CORPORATION | 15 | $512 |
| Galderma Laboratories, L.P. | 17 | $464 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 21 | $406 |
| Novartis Pharmaceuticals Corporation | 15 | $402 |
| UCB, Inc. | 10 | $238 |
| LEO Pharma Inc. | 8 | $233 |
| Organon LLC | 8 | $169 |
| ABBVIE INC. | 8 | $158 |
| Regeneron Healthcare Solutions, Inc. | 7 | $143 |
Products named: DUPIXENT, Opzelura, NEMLUVIO, COSENTYX, ILUMYA, Bimzelx, ADBRY, VTAMA.
Industry payments across TX — which companies pay providers there.
